212 related articles for article (PubMed ID: 28471171)
1. Characterizing the Chemical Space of ERK2 Kinase Inhibitors Using Descriptors Computed from Molecular Dynamics Trajectories.
Ash J; Fourches D
J Chem Inf Model; 2017 Jun; 57(6):1286-1299. PubMed ID: 28471171
[TBL] [Abstract][Full Text] [Related]
2. In silico screening and study of novel ERK2 inhibitors using 3D QSAR, docking and molecular dynamics.
Larif S; Salem CB; Hmouda H; Bouraoui K
J Mol Graph Model; 2014 Sep; 53():1-12. PubMed ID: 25064438
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
4. How good are ensembles in improving QSAR models? The case with eCoRIA.
Khedkar VM; Joseph J; Pissurlenkar R; Saran A; Coutinho EC
J Biomol Struct Dyn; 2015; 33(4):749-69. PubMed ID: 24754910
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning From Molecular Dynamics Trajectories to Predict Caspase-8 Inhibitors Against Alzheimer's Disease.
Jamal S; Grover A; Grover S
Front Pharmacol; 2019; 10():780. PubMed ID: 31354494
[TBL] [Abstract][Full Text] [Related]
6. Benchmarking 2D/3D/MD-QSAR Models for Imatinib Derivatives: How Far Can We Predict?
Kyaw Zin PP; Borrel A; Fourches D
J Chem Inf Model; 2020 Jul; 60(7):3342-3360. PubMed ID: 32623886
[TBL] [Abstract][Full Text] [Related]
7. Structure-based quantitative structure-activity relationship studies of checkpoint kinase 1 inhibitors.
Du J; Xi L; Lei B; Lu J; Li J; Liu H; Yao X
J Comput Chem; 2010 Nov; 31(15):2783-93. PubMed ID: 20839304
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of p38α mitogen-activated protein kinase inhibitors through 3D-QSAR and molecular dynamics simulations.
Chang HW; Chung FS; Yang CN
J Chem Inf Model; 2013 Jul; 53(7):1775-86. PubMed ID: 23808966
[TBL] [Abstract][Full Text] [Related]
9. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
10. Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors.
Rudolph J; Xiao Y; Pardi A; Ahn NG
Biochemistry; 2015 Jan; 54(1):22-31. PubMed ID: 25350931
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling studies on series of Btk inhibitors using docking, structure-based 3D-QSAR and molecular dynamics simulation: a combined approach.
Balasubramanian PK; Balupuri A; Cho SJ
Arch Pharm Res; 2016 Mar; 39(3):328-39. PubMed ID: 26699616
[TBL] [Abstract][Full Text] [Related]
12. 4D- quantitative structure-activity relationship modeling: making a comeback.
Fourches D; Ash J
Expert Opin Drug Discov; 2019 Dec; 14(12):1227-1235. PubMed ID: 31513441
[No Abstract] [Full Text] [Related]
13. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
[TBL] [Abstract][Full Text] [Related]
14. Studies of N(9)-arenthenyl purines as novel DFG-in and DFG-out dual Src/Abl inhibitors using 3D-QSAR, docking and molecular dynamics simulations.
Ma S; Zeng G; Fang D; Wang J; Wu W; Xie W; Tan S; Zheng K
Mol Biosyst; 2015 Feb; 11(2):394-406. PubMed ID: 25406390
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking, 3D QSAR and dynamics simulation studies of imidazo-pyrrolopyridines as janus kinase 1 (JAK 1) inhibitors.
Itteboina R; Ballu S; Sivan SK; Manga V
Comput Biol Chem; 2016 Oct; 64():33-46. PubMed ID: 27244086
[TBL] [Abstract][Full Text] [Related]
16. Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase.
Bagdanoff JT; Jain R; Han W; Poon D; Lee PS; Bellamacina C; Lindvall M
Bioorg Med Chem Lett; 2015 Sep; 25(17):3626-9. PubMed ID: 26144345
[TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics Simulations in Designing DARPins as Phosphorylation-Specific Protein Binders of ERK2.
Gautam V; Nimmanpipug P; Zain SM; Rahman NA; Lee VS
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361694
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.
Chohan TA; Chen JJ; Qian HY; Pan YL; Chen JZ
Mol Biosyst; 2016 Apr; 12(4):1250-68. PubMed ID: 26883408
[TBL] [Abstract][Full Text] [Related]
19. A comparison between 2D and 3D descriptors in QSAR modeling based on bio-active conformations.
Bahia MS; Kaspi O; Touitou M; Binayev I; Dhail S; Spiegel J; Khazanov N; Yosipof A; Senderowitz H
Mol Inform; 2023 Apr; 42(4):e2200186. PubMed ID: 36617991
[TBL] [Abstract][Full Text] [Related]
20. Assessing potency of c-Jun N-terminal kinase 3 (JNK3) inhibitors using 2D molecular descriptors and binary QSAR methodology.
Ijjaali I; Petitet F; Dubus E; Barberan O; Michel A
Bioorg Med Chem; 2007 Jun; 15(12):4256-64. PubMed ID: 17451961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
